EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access · CC BY 4.0

Feasibility and safety of “fast-track” protocol after TAVI

Sami Rahmani, Julien Polo, Jeremy Boyer, Thomas Roussel, Pierre Morera, Nicolas Jaussaud, Alizée Porto, Frédéric Collart, Pierre Deharo, Thomas Cuisset

Archives of Cardiovascular Diseases · 2026-10 · 119 (10) · 659-667

DOI: 10.1016/j.acvd.2026.04.006 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift Archives of Cardiovascular Diseases, 2026-10. Verfasst von Sami Rahmani und 9 weiteren Autor:innen. Beteiligte Einrichtung: Département de Cardiologie, CHU Timone, 264, rue Saint-Pierre, 13005 Marseille, France. Electronic address: sami.rahmani@ap-hm.fr. Hauptthemen laut MEDLINE: Aortic Valve Stenosis, Transcatheter Aortic Valve Replacement, Patient Discharge, Length of Stay. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Transcatheter aortic valve implantation is the standard treatment for symptomatic severe aortic stenosis. Advances in technology and minimally invasive techniques have made early discharge following transcatheter aortic valve implantation a feasible and safe option, optimizing hospital resource utilization without compromising care quality. AIM: To evaluate the feasibility and safety of early discharge ("fast-track") following transcatheter aortic valve implantation in a single high-volume centre. METHODS: This single-centre retrospective study included consecutive patients undergoing transcatheter aortic valve implantation (TAVI) for symptomatic severe aortic stenosis between April 2022 and December 2023. Patients were stratified into FT- (ineligible), FT+/+ (next day discharge achieved), and FT+/- (early discharge failed) groups. The primary endpoint was a 3-month composite safety outcome. RESULTS: Between April 2022 and December 2023, 506 patients aged>18 years with severe symptomatic aortic stenosis underwent transcatheter aortic valve implantation at the University Hospital of Marseille Timone; of these, 479 patients were included in the analysis. Overall, 80.8% (n=409; 95% confidence interval 77.2-84.0%) of the total patient population were eligible for fast track (FT+). The primary reason for ineligibility (FT-) was the presence of complete right bundle branch block (49.6%, n=54; 95% confidence interval 40.1-59.2%). Among FT+ patients, 69.9% (n=286; 95% confidence interval 65.3-74.1%) were discharged the next day (FT+/+); the early discharge strategy failed in 30.1% (n=123) (FT+/-). Prolonged rhythm monitoring as a result of acquired conduction disorders delayed discharge in 55.9% (n=76; 95% confidence interval 47.0-64.3%) of FT+/- cases. High-grade conduction disorders necessitated a mean wait of 4.1 days for pacemaker implantation. At 3-month follow-up, cardiovascular events occurred in 4.4% (n=12/275) of FT+/+ patients, 6.9% (n=8/116) of FT+/- patients and 11.4% (n=10/88) of FT- patients (P=0.06). CONCLUSIONS: Next-day discharge after transcatheter aortic valve implantation was feasible and safe for 69.9% of eligible patients (representing 56.5% of the overall cohort). Eligibility for the fast track protocol was achieved in 80.8% of patients. Conduction disturbances and vascular complications remain key obstacles leading to prolonged hospital stays and requiring optimization.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aortic Valve StenosisTranscatheter Aortic Valve ReplacementPatient DischargeLength of StayAortic ValveHumansFeasibility StudiesRetrospective StudiesTime FactorsAged, 80 and overTreatment OutcomeFemaleRisk FactorsMaleAgedSeverity of Illness IndexRisk AssessmentFranceRecovery of FunctionPostoperative Complications

Stichwörter der Autor:innen

Patient dischargeTranscatheter aortic valve replacement

Autor:innen und Institutionen

  • Département de Cardiologie, CHU Timone, 264, rue Saint-Pierre, 13005 Marseille, France. Electronic address: sami.rahmani@ap-hm.fr.
  • Département de Cardiologie, CHU Timone, 264, rue Saint-Pierre, 13005 Marseille, France.
  • Département de Chirurgie Cardiaque, CHU Timone, 13005 Marseille, France.
  • Département de Chirurgie Cardiaque, CHU Timone, 13005 Marseille, France; Inserm, Inra, C2VN, Aix-Marseille La Timone University, 13005 Marseille, France; Faculté de Médecine, Aix-Marseille University, 13005 Marseille, F…
  • Département de Cardiologie, CHU Timone, 264, rue Saint-Pierre, 13005 Marseille, France; Inserm, Inra, C2VN, Aix-Marseille La Timone University, 13005 Marseille, France; Faculté de Médecine, Aix-Marseille University, 130…

Zitieren

APA

Rahmani, S., Polo, J., Boyer, J., Roussel, T., Morera, P., Jaussaud, N., Porto, A., Collart, F., Deharo, P., & Cuisset, T. (2026). Feasibility and safety of “fast-track” protocol after TAVI. Archives of Cardiovascular Diseases, 119(10), 659-667. https://doi.org/10.1016/j.acvd.2026.04.006

Vancouver

Rahmani S, Polo J, Boyer J, Roussel T, Morera P, Jaussaud N, et al. Feasibility and safety of “fast-track” protocol after TAVI. Archives of Cardiovascular Diseases. 2026;119(10):659-667. doi:10.1016/j.acvd.2026.04.006

BibTeX
@article{Rahmani2026,
  author = {Rahmani, Sami and Polo, Julien and Boyer, Jeremy and Roussel, Thomas and Morera, Pierre and Jaussaud, Nicolas and Porto, Alizée and Collart, Frédéric and Deharo, Pierre and Cuisset, Thomas},
  title = {Feasibility and safety of “fast-track” protocol after TAVI},
  journal = {Archives of Cardiovascular Diseases},
  year = {2026},
  volume = {119},
  number = {10},
  pages = {659--667},
  doi = {10.1016/j.acvd.2026.04.006}
}
Kostenlos starten →